Advanced search
Publication Cover
Cancer Management and Research Volume 11, 2019 - Issue
Submit an article Journal homepage
106
Views
11
CrossRef citations to date
0
Altmetric
Original Research

Candidate tumor suppressor gene IRF6 is involved in human breast cancer pathogenesis via modulating PI3K-regulatory subunit PIK3R2 expression

Hong-Fa Xu1 Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou510060, People’s Republic of China;2 Zhuhai Precision Medical Center, Zhuhai People’s Hospital Affiliated to Jinan University, Zhuhai519000, People’s Republic of China
,
Tie-Jun Huang3 Department of Nuclear Medicine, The Second People’s Hospital of Shenzhen, Shenzhen518035, People’s Republic of China
,
Qin Yang1 Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou510060, People’s Republic of China
,
Liang Xu1 Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou510060, People’s Republic of China
,
Fen Lin1 Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou510060, People’s Republic of China
,
Yan-Hong Lang1 Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou510060, People’s Republic of China
,
Hao Hu4 Department of Traditional Chinese Medicine, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou510060, People’s Republic of China
,
Li-Xia Peng1 Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou510060, People’s Republic of China
,
Dong-Fang Meng1 Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou510060, People’s Republic of China
,
Yu-Jie Xie1 Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou510060, People’s Republic of China
,
Li Tan5 Center of Hematology, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou510230, People’s Republic of ChinaCorrespondence[email protected]
,
Chao-Nan Qian1 Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou510060, People’s Republic of China
&
Bi-Jun Huang1 Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou510060, People’s Republic of ChinaCorrespondence[email protected]
 show all
Pages 5557-5572 | Published online: 21 Jun 2019

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Adrija Mohanta, Rajiv R Kumar, Rahul K Singh, Surojit Mandal, Ritu Yadav, Rinku Khatkar, Uttam Sharma, Vivek Uttam, Manjit K Rana, Amrit PS Rana & Aklank Jain. (2023) Emerging Role of miR-320a in Lung Cancer: A Comprehensive Review. Biomarkers in Medicine 17:18, pages 767-781.
Read now
Lin Tan, Weiming Qu, Dajun Wu, Minji Liu, Qiongjia Ai, Hongsai Hu, Qian Wang, Weishun Chen & Hongbing Zhou. (2022) The interferon regulatory factor 6 promotes cisplatin sensitivity in colorectal cancer. Bioengineered 13:4, pages 10504-10517.
Read now
Jun Wu, Xuefeng Leng, Zhengbo Pan, Linfei Xu & Haitao Zhang. (2021) Overexpression of IRF3 Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma. International Journal of General Medicine 14, pages 5675-5692.
Read now

Articles from other publishers (8)

Jianguo Wang, Shizhong Cai, Qianwei Xiong, Deyu Weng, Qian Wang & Zhourui Ma. (2022) PIK3R2 predicts poor outcomes for patients with melanoma and contributes to the malignant progression via PI3K/AKT/NF-κB axis. Clinical and Translational Oncology 25:5, pages 1402-1412.
Crossref
Michael Bauer, Valentina Todorova, Annjanette Stone, Weleetka Carter, Matthew Plotkin, Ping-Ching Hsu, Jeanne Wei, Joseph Su & Issam Makhoul. (2021) Genome-Wide DNA Methylation Signatures Predict the Early Asymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer. Cancers 13:24, pages 6291.
Crossref
Hui Zhao, Junjun Zhang, Xiaoliang Fu, Dongdong Mao, Xuesen Qi, Shuai Liang, Gang Meng, Zewen Song, Ru Yang, Zhenni Guo, Binghua Tong, Meiqing Sun, Baile Zuo & Guoyin Li. (2021) Integrated bioinformatics analysis of the NEDD4 family reveals a prognostic value of NEDD4L in clear-cell renal cell cancer . PeerJ 9, pages e11880.
Crossref
Jie Wu, Yan Cai, Gaiping Zhao & Maolan Li. (2021) A ten N6‐methyladenosine‐related long non‐coding RNAs signature predicts prognosis of triple‐negative breast cancer. Journal of Clinical Laboratory Analysis 35:6.
Crossref
Daoyuan Tu, Jin Dou, Mingkao Wang, Haiwen Zhuang & Xiaoyu Zhang. (2021) M2 macrophages contribute to cell proliferation and migration of breast cancer. Cell Biology International 45:4, pages 831-838.
Crossref
Yunpeng Liu, Guoguang Shao, Zhiguang Yang, Xingyu Lin, Xing Liu, Benxin Qian & Zihao Liu. (2021) Interferon regulatory factor 6 correlates with the progression of non-small cell lung cancer and can be regulated by miR-320. Journal of Pharmacy and Pharmacology 73:5, pages 682-691.
Crossref
Yuefang Ren, Jie Dong, Pingya He, Yufei Liang, Lifang Wu, Jiajian Wang & Boliang Chu. (2020) miR‐587 promotes cervical cancer by repressing interferon regulatory factor 6. The Journal of Gene Medicine 22:11.
Crossref
Rao Fu & Jing‐Shan Tong. (2020) miR‐126 reduces trastuzumab resistance by targeting PIK3R2 and regulating AKT/mTOR pathway in breast cancer cells. Journal of Cellular and Molecular Medicine 24:13, pages 7600-7608.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.